Mutated form of arginine deiminase
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 21, 2003
Grant Date -
N/A
app pub date -
May 4, 2000
filing date -
May 12, 1997
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention discloses arginine deiminase that is genetically modified for more efficient manufacturing and processing. The present invention discloses recombinant DNA molecules and vectors and other therapeutic and pharmaceutical compositions. The present invention also discloses methods for preparing modified arginine deiminase as well as methods of treating cancer and other disease states using modified arginine deiminase.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully